ESC Premium Access

Cost-effectiveness of semaglutide for secondary prevention of cardiovascular disease in the United States

Congress Presentation

About the speaker

Doctor Susan Hennessy

University of California at San Francisco, San Francisco (United States of America)
0 follower

4 more presentations in this session

Cost differences between oral anticoagulation therapies in atrial fibrillation patients

Speaker: Mr O. Lehtonen (Kuopio, FI)

Thumbnail

Disparities by region, age, and sex in cardiovascular disease burden attributable to high fasting plasma glucose in China, 2010-2018: a nationwide, population-based study.

Speaker: Miss X. Cao (Beijing, CN)

Thumbnail

Embedding a text message recall system to increase the uptake of cardiovascular screening in Australian general practice. Results of the Text to Detect randomised controlled trial

Speaker: Miss N. Raffoul (Sydney, AU)

Thumbnail

Independent associations of educational attainment and its joint associations with LE8 score for risk of cardiovascular disease incidence and mortality among Chinese people

Speaker: Doctor Z. Chen (Changsha, CN)

Thumbnail

Access the full session

Disparities: insights into socioeconomic factors and cardiovascular health

Speakers: Doctor S. Hennessy, Mr O. Lehtonen, Miss X. Cao, Miss N. Raffoul, Doctor Z. Chen
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations